OPA1 and retinal degeneration: In a murine model of DOA, caused by mutation c.2708_2711delTTAG in Opa1 gene, IVT injection of AAV2 carrying the human OPA1 cDNA under the control of the cytomegalovirus promoter resulted in the prevention of retinal degeneration [121].